The role of biomarkers in the diagnosis of COVID-19 - A systematic review
As of the 28th April 2020, the COVID-19 pandemic has infiltrated over 200 countries and affected over three million confirmed people. Only studies that reported data on pre-defined outcomes were included. Thirty-four relevant articles were identified which reviewed the following biomarkers. Lymphocytes and platelet count showed significantly lower levels in severe patients. Research is still in its early stages but could help clinicians identify severe diseases earlier and improve prognosis
